LiverPRO

Early detection of liver fibrosis in primary care.

Overview

LiverPRO is a clinical decision support tool designed for primary care settings to enable early detection of liver fibrosis. By analyzing common laboratory results from a standard blood test, along with the patient's age, the software calculates a risk score. This allows general practitioners to identify asymptomatic patients at high risk for liver disease, facilitating timely intervention or referral to a specialist before the condition becomes severe.

✨ Key Features

  • Predicts risk of liver fibrosis
  • Uses standard blood test results
  • Designed for primary care settings
  • Non-invasive screening tool
  • Aids in early detection of liver disease

🎯 Key Differentiators

  • Specifically designed as an integrated software tool for ease of use
  • Developed and validated for primary care workflows
  • Aims to be integrated directly into routine blood test reporting

Unique Value: Makes screening for liver fibrosis easy, inexpensive, and accessible to primary care physicians, enabling early detection on a massive scale.

🎯 Use Cases (4)

Screening for liver fibrosis in patients with risk factors (e.g., obesity, diabetes) Identifying patients who need further specialist evaluation Avoiding unnecessary examinations for low-risk patients Facilitating early intervention for liver disease

✅ Best For

  • Early-stage detection of liver fibrosis in primary care populations.

💡 Check With Vendor

Verify these considerations match your specific requirements:

  • Full practice management or clinical charting
  • Diagnosing specific causes of liver disease

🏆 Alternatives

FIB-4 Index calculators NAFLD Fibrosis Score calculators

Offers a more streamlined and potentially more accurate prediction integrated into clinical workflow compared to manual calculation of existing scores like FIB-4.

💻 Platforms

Web

🔌 Integrations

EHR systems (intended)

🔒 Compliance & Security

✓ HIPAA ✓ BAA Available

💰 Pricing

Contact for pricing
Free Tier Available

Free tier: Likely free for clinical use as a decision support tool.